Five Oceans Advisors Reduces Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Five Oceans Advisors lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 14.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,720 shares of the company’s stock after selling 2,708 shares during the period. Five Oceans […]

Related Keywords

Japan , ,Schonfeld Strategic Advisors ,Takeda Pharmaceutical Company ,Citigroup Inc ,Takeda Pharmaceutical Company Limited ,Exchange Commission ,Co Ltd Takeda ,Five Oceans Advisors ,Free Report ,Oceans Advisor ,Takeda Pharmaceutical ,Global Investments ,Investment Partners ,Pharmaceutical Stock Down ,Pharmaceutical Company Limited ,Get Free Report ,Pharmaceutical Co Ltd Takeda ,Takeda Pharmaceutical Daily ,Nyse Tak ,Tak ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,